Search

(GLOBE NEWSWIRE via COMTEX) -- CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer's Disease [...]

(GLOBE NEWSWIRE via COMTEX) -- - Ribociclib (Kisqali) plus aromatase inhibitor (AI) recommended for HR+/HER2- early breast cancer (EBC) node-positive and high-risk node-negative patients, as studied in the NATALEE trial [...]

SYDNEY, October 22, 2024 (Xinhua via COMTEX) -- A large-scale study of brain volumes by an Australian institute published on Tuesday has revealed links between genetic variants in brain size [...]

(GLOBE NEWSWIRE via COMTEX) -- Global 600 patient study will evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. Rhu-pGSN is an immune system regulator that [...]

CANBERRA, October 21, 2024 (Xinhua via COMTEX) -- Australia's peak medical research authority has recommended significantly cutting the country's acceptable limits of 'forever chemicals' in drinking water. The National Health [...]

(GLOBE NEWSWIRE via COMTEX) -- -- BPT567 is the first bifunctional PD1-IL18 immunoconjugate to enter clinical development -- -- Phase 1/2a study will evaluate BPT567 in patients with locally advanced/unresectable [...]

(GLOBE NEWSWIRE via COMTEX) -- - Neuropathic corneal pain (NCP) is listed in the National Organization for Rare Disorders (NORD) as an orphan disease - OKYO is the first company [...]

(GLOBE NEWSWIRE via COMTEX) -- - Inventiva secures EUR94.1 million of a multi-tranche equity financing of up to EUR348 million, subject to satisfaction of specified conditions, from both new and [...]

(GLOBE NEWSWIRE via COMTEX) -- Drs. Lieberman, Collman, and Co-Authors Link RSAD2/Viperin Gene with Certain Chronically HIV-Infected Cells Philadelphia, PA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- New findings could lead [...]

(GLOBE NEWSWIRE via COMTEX) -- DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients into Cohort 3 ROCKVILLE, Md., [...]

(GLOBE NEWSWIRE via COMTEX) -- - Improved precision of the AI-Immunology(TM) platform in predicting clinically relevant vaccine targets boosts the potential of its AI-derived vaccine candidates - The improvement has [...]

LOS ANGELES, September 27, 2024 (Xinhua via COMTEX) -- U.S. researchers have identified a gene responsible for some inherited retinal diseases (IRDs), which are a group of disorders that damage [...]

(GLOBE NEWSWIRE via COMTEX) -- MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and [...]

BEIJING, September 26, 2024 (Xinhua via COMTEX) -- Chinese scientists have realized the clinical cure of a type 1 diabetes patient by transplanting islet cells derived from chemically induced pluripotent [...]

LOS ANGELES, September 24, 2024 (Xinhua via COMTEX) -- Fewer than half of 1,028 jails surveyed across the United States offered any form of medication for opioid use disorder, according [...]

(GLOBE NEWSWIRE via COMTEX) -- BASEL, Sept. 24, 2024 -- ARTIDIS today announced the appointment of Dr. Julie Louise Gerberding to its Board of Directors, effective immediately. Dr. Gerberding is [...]

(GLOBE NEWSWIRE via COMTEX) -- Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU - Confirming the results of CUPID-A, this second pivotal study [...]

Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases There are currently no fully approved agents for the treatment of relapsed PTCL and soquelitinib [...]

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (DBA Lifeward(TM)) (Nasdaq: LFWD) ('Lifeward' or the 'Company'), a global market leader delivering life-changing solutions [...]

WATERTOWN, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. ('Acrivon' or 'Acrivon Therapeutics') (Nasdaq: ACRV), a clinical stage precision medicine company utilizing its Acrivon Predictive Precision Proteomics (AP3) [...]

2.5 mg dose restored normative wakefulness with mean sleep latency of 32 minutes as measured by the Maintenance of Wakefulness Test (MWT) Favorable safety and tolerability profile with no observations [...]

(GLOBE NEWSWIRE via COMTEX) -- - 2.5 mg dose restored normative wakefulness with mean sleep latency of 32 minutes as measured by the Maintenance of Wakefulness Test (MWT) - Favorable [...]

SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that the [...]

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ('Psyence Biomed' or the 'Company'), a developer of naturally derived psilocybin-based therapeutics, today announced that the first [...]

Outcomes is the third study in the Phase 3 SYNCHRONY clinical trial program SOUTH SAN FRANCISCO, Calif., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage [...]

- Webcast investor event on September 14, 2024 at 9:00 a.m. ET -ESMO poster presentation to provide updated ACR-368 clinical data in endometrial cancer -Webcast to provide updates on its [...]

Wauwasota, WI, and Cambridge, UK, Sept. 06, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=fHsY210JgoCR0qGA9t-t9SaiMEL41U_kP9hySeLtXs3Cx4Xv75_Qp6egOGbx0HQEeyD7gCuc-ypFOG6c5jZt-BDxXfsryKWnmcbnAweUSMg=, the new standard in patient recruitment solutions, and https://www.globenewswire.com/Tracker?data=kp7JtVHeBRUBDtzrLNRv_F2Kri8bdo7uwxyPA_wAPO1Mn_CN__pZZeeM72WOWZihcR3-d4K_dP0xtWibeAYyBy0oL2YDtrpw7U33VamlA18= (AIM: COG), a leading provider of digital health solutions [...]

Trem-cel + Mylotarg demonstrated engraftment, shielding, broadened therapeutic window, and patient benefit VCAR33 [sup. ALLO ] demonstrates encouraging biomarker data at lowest dose New asset VADC45 with significant potential opportunities [...]

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- DeepHealth, a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered radiology and health informatics, today announces a [...]

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Merakris Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has granted clearance to commence Part 2 of [...]

VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- This September, https://www.globenewswire.com/Tracker?data=OuuhHpAT_vYffztnzv9nuBZAxCFy0FkW2Ihl2pCDbLlZakS1S2Ae064DVs7cgqjQQm-XtSunwOlr2cWI30Fprr-SEyn1kmY90FL_1O3_dJo= joins forces with https://www.globenewswire.com/Tracker?data=3SlPQ7Sjhh-YbofE_ARlqzCxSCuO_pjmOo0mr-CQ250Z4QH29smdnnLVbV7aNohSIpE83ezwbWMLwX04BDmxgA==, an organization dedicated to finding a cure for ALS (Amyotrophic Lateral Sclerosis), also known [...]

CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- https://www.globenewswire.com/Tracker?data=pD6JqpllxYqQbN2z5wCioOwKmoScKtGB688CQqsi8dFPoD95uHrr_BOZxDNhhlUiaSkgvRc-eXqbmpC1bTez18OfbeJOynFlyk4RH6vuBkw=, a clinical-stage biopharmaceutical company focused on development of inhaled therapies for treatment of life-threatening pulmonary diseases, today announced the initiation of [...]

SYDNEY, September 3, 2024 (Xinhua via COMTEX) -- Australian researchers have created lab-grown blood stem cells that closely resemble those in the human body in a world-first that could lead [...]

(GLOBE NEWSWIRE via COMTEX) -- - Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study [...]

Dr. Scholl is a globally recognized leader in the field of ophthalmology and the coordinating principal investigator of the largest ever natural history study of Stargardt disease SAN DIEGO, Sept. [...]

LONDON, Ontario, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Children's Hospital at London Health Sciences Centre (LHSC) and Shriners Hospitals for Children Canada (SHC Canada) have announced a first of its [...]

FDA Final Approval to Precision Dosing for GLOPERBA[sup.(R)] Label. We believe GLOPERBA[sup.(R)] is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of [...]

CHICAGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for sarcoidosis patients, [...]

(GLOBE NEWSWIRE via COMTEX) -- - Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C reduction1 - Results [...]

(GLOBE NEWSWIRE via COMTEX) -- ADELAIDE, Australia and WAKE FOREST, N.C., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, a leading global CRO specializing in clinical trials for the biotech [...]

ADELAIDE, Australia and WAKE FOREST, N.C., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious [...]

JERUSALEM, August 27, 2024 (Xinhua via COMTEX) -- A recently released study has revealed that symptoms of mental disorders such as depression and anxiety present in predictably structured ways. The [...]

Salt Lake City, UT, Aug. 27, 2024 (GLOBE NEWSWIRE) -- CenExel, a leading clinical trial network, is pleased to announce the appointment of Patrick McLaughlin as Chief Operating Officer (COO). [...]

Study further validates highly reproducible drug response data. Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen market valued at $4.4 billion in 2023, expected [...]

CAMBRIDGE, United Kingdom, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Microbiotica, a biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), is pleased to announce [...]

New York, Aug. 26, 2024 (GLOBE NEWSWIRE) -- September marks the kick-off of the Muscular Dystrophy Association (MDA) 'National Muscular Dystrophy Awareness Month' to raise awareness and critical funds for [...]

(GLOBE NEWSWIRE via COMTEX) -- RIYADH, Saudi Arabia, Aug. 23, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) solidifies its medical education and research leadership through [...]

TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (' PharmAla ' or the ' Company ') (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, [...]

BOSTON, Aug. 22, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced its recent feature in Fortune [...]

SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ('Skye'), a clinical-stage biopharmaceutical company focused on unlocking new therapeutic pathways for metabolic health, has started screening [...]